Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study (Q86592713)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 January 2015
edit
Language Label Description Also known as
English
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
scientific article published on 25 January 2015

    Statements

    title
    Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    25618415
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25618415%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    28 February 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q86592713&oldid=2221824193"